Elucidata is a bioinformatics company that specializes in transforming biomedical big data into actionable insights for drug discovery and development. Through its proprietary platform, Polly, Elucidata integrates diverse data types and sources to enhance data accessibility, interoperability, and utility for life sciences research. By leveraging machine learning and data-driven approaches, the company aims to accelerate the development of novel therapeutics and advance precision medicine. Elucidata serves a range of clients in academia and industry, offering solutions for data curation, integration, and analysis to improve research outcomes.